Ignite Creation Date:
2024-07-17 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06464367
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-08
Brief Title:
Mechanistic Studies of Psilocybin in Headache Disorders
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
Mechanistic Studies of Psilocybin in Headache Disorders
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In previous clinical trial work the investigators observed lasting reductions in headache burden after limited dosing of psilocybin This purpose of this study is to examine potential sources for this observed effect This study will measure brain resting state functional connectivity fMRI central synaptic density SV2A PET peripheral markers of inflammation circadian rhythm actigraphy and sleep sleep EEG in both migraine and healthy control participants before and one week after the administration of psilocybin or an active control agent
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ES0006 | OTHER | None | None |